These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 97712)

  • 1. Neuropharmacological and behavioral evaluation of prostaglandin E2 and 11-thiol-11-desoxy prostaglandin E2 in the mouse and rat.
    Bloss JL; Singer GH
    Psychopharmacology (Berl); 1978 May; 57(3):295-302. PubMed ID: 97712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of the nueroleptic properties of clozapine, sulpiride and thioridazine.
    Costall B; Naylor RJ
    Psychopharmacologia; 1975 Jul; 43(1):69-74. PubMed ID: 1172258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical antipsychotic drugs block selective components of amphetamine-induced stereotypy.
    Tschanz JT; Rebec GV
    Pharmacol Biochem Behav; 1988 Nov; 31(3):519-22. PubMed ID: 3251235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The behavioral pharmacology of butaclamol hydrochloride (AY-23,028), a new potent neuroleptic drug.
    Voith K; Herr F
    Psychopharmacologia; 1975 Apr; 42(1):11-20. PubMed ID: 1171496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of thioridazine on haloperidol induced behavioral hypersensitivity.
    Klawans HL; Carvey PM; Nelson D; Tanner CM; Goetz CG
    Life Sci; 1986 May; 38(19):1707-14. PubMed ID: 3702600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The action of neuroleptics in rats with altered catecholamine metabolism. I. The influence of MAO inhibitors on the behavioral actions of chlorpromazine, haloperidol, and thioridazine.
    Vetulani J
    Pol J Pharmacol Pharm; 1973; 25(1):41-52. PubMed ID: 4798098
    [No Abstract]   [Full Text] [Related]  

  • 7. Atypical neuroleptics clozapine and thioridazine enhance amphetamine-induced stereotypy.
    Robertson A; MacDonald C
    Pharmacol Biochem Behav; 1984 Jul; 21(1):97-101. PubMed ID: 6540455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of neuroleptics and tricyclic antidepressants upon d-amphetamine discrimination.
    Schechter MD
    Pharmacol Biochem Behav; 1980 Jan; 12(1):1-5. PubMed ID: 6102768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pentadecapeptide BPC 157 attenuates disturbances induced by neuroleptics: the effect on catalepsy and gastric ulcers in mice and rats.
    Jelovac N; Sikiric P; Rucman R; Petek M; Marovic A; Perovic D; Seiwerth S; Mise S; Turkovic B; Dodig G; Miklic P; Buljat G; Prkacin I
    Eur J Pharmacol; 1999 Aug; 379(1):19-31. PubMed ID: 10499368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypokinesia in mice and catalepsy in rats elicited by morphine associated with antidopaminergic agents, including atypical neuroleptics.
    Barghon R; Protais P; Colboc O; Costentin J
    Neurosci Lett; 1981 Nov; 27(1):69-73. PubMed ID: 6120489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Locomotor stereotypy is produced by methylphenidate and amfonelic acid and reduced by haloperidol but not clozapine or thioridazine.
    Mueller K
    Pharmacol Biochem Behav; 1993 May; 45(1):71-6. PubMed ID: 8100075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral evidence for supersensitivity after chronic administration of haloperidol, clozapine, and thioridazine.
    Smith RC; Davis JM
    Life Sci; 1976 Sep; 19(5):725-31. PubMed ID: 986527
    [No Abstract]   [Full Text] [Related]  

  • 13. Behavioral and electroencephalographic effects of a depot type neuroleptic fluphenazine decanoate, in rats.
    Yamamoto T; Ueki S
    J Pharmacobiodyn; 1989 Nov; 12(11):681-92. PubMed ID: 2632765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of acquisition of one-way conditioned avoidance responding by haloperidol and metoclopramide but not by thioridazine or clozapine: implications for screening new antipsychotic drugs.
    Blackburn JR; Phillips AG
    Psychopharmacology (Berl); 1989; 98(4):453-9. PubMed ID: 2570431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiation of cataleptogenic effects of neuroleptics by prostaglandins.
    Herman ZS; Słomińska-Zurek J; Kryk A; Kmieciak-Kołada K
    Pol J Pharmacol Pharm; 1978; 30(5):639-46. PubMed ID: 35782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further studies on the neuroleptic profile of manassantin A.
    Rao KV; Puri VN; el-Sawaf HA
    Eur J Pharmacol; 1990 Apr; 179(3):367-76. PubMed ID: 1973109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the effects of neuroleptics on phencyclidine-induced behaviors in the rat.
    Sturgeon RD; Fessler RG; London SF; Meltzer HY
    Eur J Pharmacol; 1981 Nov; 76(1):37-53. PubMed ID: 6119221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential liabilities of haloperidol and thioridazine for inducing apomorphine hypersensitivity.
    De Veaugh-Geiss J; Devanand DP; Carey RJ
    Biol Psychiatry; 1982 Nov; 17(11):1289-301. PubMed ID: 6891268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropharmacological profile of MD 790501, a new benzamide derivative.
    Jalfre M; Bucher B; Dorme N; Mocquet G; Porsolt RD
    Arch Int Pharmacodyn Ther; 1983 Aug; 264(2):232-56. PubMed ID: 6139097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of dyskinesias following the intrastriatal injection of prostaglandins in the rodent.
    Costall B; Holmes SW; Kelly ME; Naylor RJ
    Br J Pharmacol; 1985 Aug; 85(4):943-9. PubMed ID: 3862460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.